Tien Liang BioTech Co., Ltd. (4127.TWO)

TWD 40.9

(0.25%)

Operating Income Summary of Tien Liang BioTech Co., Ltd.

  • Tien Liang BioTech Co., Ltd.'s latest annual operating income in 2023 was 20.43 Million TWD , down -69.01% from previous year.
  • Tien Liang BioTech Co., Ltd.'s latest quarterly operating income in 2024 Q2 was -2.64 Million TWD , down -147.39% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported an annual operating income of 61.1 Million TWD in 2022, up 20.67% from previous year.
  • Tien Liang BioTech Co., Ltd. reported an annual operating income of 50.63 Million TWD in 2021, up 208.58% from previous year.
  • Tien Liang BioTech Co., Ltd. reported a quarterly operating income of -2.64 Million TWD for 2024 Q2, down -147.39% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported a quarterly operating income of 8.86 Million TWD for 2023 Q4, up 1042.4% from previous quarter.

Annual Operating Income Chart of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 20.43 Million TWD -69.01%
2022 61.1 Million TWD 20.67%
2021 50.63 Million TWD 208.58%
2020 -46.63 Million TWD -7.4%
2019 -43.41 Million TWD 0.0%

Peer Operating Income Comparison of Tien Liang BioTech Co., Ltd.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 76.964%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 86.692%
Easywell Biomedicals, Inc. -162.73 Million TWD 112.558%
TTY Biopharm Company Limited 1.37 Billion TWD 98.511%
Synmosa Biopharma Corporation 614.74 Million TWD 96.676%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 75.831%
Center Laboratories, Inc. -79.26 Million TWD 125.782%
Orient Pharma Co., Ltd. 27.75 Million TWD 26.365%
InnoPharmax Inc. -64.83 Million TWD 131.518%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 80.642%
Excelsior Biopharma Inc. -81.12 Million TWD 125.19%
DV Biomed Co., Ltd. 173.54 Million TWD 88.225%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 102.028%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 97.063%
UniPharma Co., Ltd. -27.3 Million TWD 174.843%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD 61.552%
Alar Pharmaceuticals Inc. 385.52 Million TWD 94.699%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 89.579%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 144.728%
Bioray Biotech Co., Ltd -19.33 Million TWD 205.716%
TSH Biopharm Corporation Limited 63.63 Million TWD 67.883%